ArticleGigaScience2025
CNSistent integration and feature extraction from somatic copy number profiles.
Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundMost cancers exhibit somatic copy number alterations (SCNAs)-gains and losses of variable regions of DNA. SCNAs play a key role in cancer adaptation through modulation of gene expression, deletion of tumor suppressor genes, or amplification of oncogenes. Systematic analysis of SCNAs is now a routine task in both the clinic and research and can help identify novel cancer genes, improve our understanding of cancer gene regulation, and enable us to accurately reconstruct cancer phylogenies. However, to conduct such analyses, SCNA profiles have to be integrated between samples, patients, and cohorts-often a nontrivial task, for which dedicated toolkits are lacking.
resultsTo fill this gap, we developed CNSistent, a Python package for imputation, filtering, consistent segmentation, feature extraction, and visualization of cancer copy number profiles from heterogeneous datasets. We demonstrate the utility of CNSistent by applying it to the following publicly available cohorts: The Cancer Genome Atlas, Pan-Cancer Analysis of Whole Genomes, and TRAcking Cancer Evolution through therapy (Rx). We compare the effect of sample preprocessing and different segmentation and aggregation strategies on cancer type and subtype classification tasks using various classification models. We also evaluate how well a classifier trained on one cohort generalizes to another. Lastly, we introduce 2 segment-based peak and outlier scores to investigate relationships between segments, between samples, and between cancer types. Using these scores, we investigate non-small cell lung cancer samples, highlighting that SOX2 amplification is the dominant copy number alteration in lung squamous cell carcinoma and the main distinction to lung adenocarcinoma.
conclusionsCNSistent is a general-purpose toolkit for integrated processing of SCNA profiles across many patients and cohorts. It is available at https://bitbucket.org/schwarzlab/cnsistent. The Research Resource Identifier for CNSistent is SCR_027025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.